My Quote Request
6505-01-368-2864
20 Products
VANTIN FOR ORAL SUSPENSION
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682864
NSN
6505-01-368-2864
VANTIN FOR ORAL SUSPENSION
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682864
NSN
6505-01-368-2864
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL FOR ORAL SUSPENSION 100MG/5ML 100ML BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 100 MG CEFPODOXIME PROXETIL PER 5 ML
Related Searches:
VANTIN
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682864
NSN
6505-01-368-2864
VANTIN
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682864
NSN
6505-01-368-2864
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL FOR ORAL SUSPENSION 100MG/5ML 100ML BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 100 MG CEFPODOXIME PROXETIL PER 5 ML
Related Searches:
NDC00009-3531-01
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
NDC00009-3531-01
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL FOR ORAL SUSPENSION 50MG/5ML 100ML BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG CEFPODOXIME PROXETIL PER 5 ML
Related Searches:
VANTIN
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
VANTIN
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL FOR ORAL SUSPENSION 50MG/5ML 100ML BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG CEFPODOXIME PROXETIL PER 5 ML
Related Searches:
VANTIN FOR ORAL SUSPENSION
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
VANTIN FOR ORAL SUSPENSION
CEFPODOXIME PROXETIL FOR ORAL SUSPENSION
NSN, MFG P/N
6505013682865
NSN
6505-01-368-2865
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL FOR ORAL SUSPENSION 50MG/5ML 100ML BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG CEFPODOXIME PROXETIL PER 5 ML
Related Searches:
A93C026
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00009-3617-02
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
NDC00009-3617-02
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VANTIN
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VANTIN TABLETS
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
VANTIN TABLETS
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682867
NSN
6505-01-368-2867
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
A93C025
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00009-3618-02
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
NDC00009-3618-02
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
VANTIN
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
VANTIN TABLETS
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
VANTIN TABLETS
CEFPODOXIME PROXETIL TABLETS
NSN, MFG P/N
6505013682870
NSN
6505-01-368-2870
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CEFPODOXIME PROXETIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFPODOXIME PROXETIL TABLETS 200MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
CAPOZIDE
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
CAPOZIDE
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CAPOZIDE TABLETS
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
CAPOZIDE TABLETS
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49884-0818-01
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
NDC49884-0818-01
CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,USP
NSN, MFG P/N
6505013682881
NSN
6505-01-368-2881
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
COBOLIN-M
CYANOCOBALAMIN INJECTION,USP
NSN, MFG P/N
6505013686576
NSN
6505-01-368-6576
COBOLIN-M
CYANOCOBALAMIN INJECTION,USP
NSN, MFG P/N
6505013686576
NSN
6505-01-368-6576
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MICROGRAMS CYANOCOBALAMIN EQUIVALENT PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-1036-25
CYANOCOBALAMIN INJECTION,USP
NSN, MFG P/N
6505013686576
NSN
6505-01-368-6576
NDC00469-1036-25
CYANOCOBALAMIN INJECTION,USP
NSN, MFG P/N
6505013686576
NSN
6505-01-368-6576
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MICROGRAMS CYANOCOBALAMIN EQUIVALENT PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
044-20211
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
044-20211
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 3.500 MILLIGRAMS CALCIUM ION ACTIVE INGREDIENT AND 132.000 MILLIGRAMS SODIUM ION ACTIVE INGREDIENT AND 102.000 MILLIGRAMS CHLORIDE ION ACTIVE INGREDIENT AND 1.500 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 LITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND LACTATE ION 35.000 MILLEQUIVALENTS ACTIVE INGREDIENT
Related Searches:
08-0211
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
08-0211
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013686577
NSN
6505-01-368-6577
MFG
MEL INC DBA PURE WATER SOLUTIONS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 3.500 MILLIGRAMS CALCIUM ION ACTIVE INGREDIENT AND 132.000 MILLIGRAMS SODIUM ION ACTIVE INGREDIENT AND 102.000 MILLIGRAMS CHLORIDE ION ACTIVE INGREDIENT AND 1.500 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 LITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND LACTATE ION 35.000 MILLEQUIVALENTS ACTIVE INGREDIENT